Mettler-Toledo International, Inc. $MTD Shares Purchased by Financial Advisors Network Inc.

Key Points

• Financial Advisors Network Inc. significantly increased its stake in Mettler-Toledo International, Inc. by 808.9%, acquiring a total of 3,254 shares worth approximately $3.84 million.
• Institutional investors collectively own 95.07% of Mettler-Toledo's stock, with notable increases in holdings from firms such as Vanguard Group and GAMMA Investing LLC.
• Mettler-Toledo reported earnings of $10.09 per share for the last quarter, exceeding estimates and marking a 3.9% year-over-year revenue growth.

Financial Advisors Network Inc. increased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 808.9% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 3,254 shares of the medical instruments supplier's stock after acquiring an additional 2,896 shares during the period. Financial Advisors Network Inc.'s holdings in Mettler-Toledo International were worth $3,843,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Mettler-Toledo International by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock valued at $3,003,485,000 after acquiring an additional 30,535 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Mettler-Toledo International by 6.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock worth $557,680,000 after purchasing an additional 25,873 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Mettler-Toledo International by 131,246.3% in the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after purchasing an additional 385,864 shares during the period. T. Rowe Price Investment Management Inc. boosted its stake in shares of Mettler-Toledo International by 36.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock valued at $444,327,000 after purchasing an additional 96,300 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in shares of Mettler-Toledo International by 2.1% in the first quarter. Principal Financial Group Inc. now owns 280,319 shares of the medical instruments supplier's stock valued at $331,032,000 after purchasing an additional 5,756 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Activity

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,389,588.55. The trade was a 5.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director owned 120 shares of the company's stock, valued at $139,191.60. The trade was a 89.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,424 shares of company stock valued at $2,989,628 over the last quarter. Corporate insiders own 0.77% of the company's stock.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD opened at $1,315.67 on Monday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,521.01. The stock has a market capitalization of $27.10 billion, a price-to-earnings ratio of 33.32, a PEG ratio of 3.94 and a beta of 1.34. The company has a 50-day simple moving average of $1,215.67 and a 200-day simple moving average of $1,188.24.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. The company's revenue for the quarter was up 3.9% on a year-over-year basis. During the same period last year, the company earned $9.65 earnings per share. As a group, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analyst Ratings Changes

MTD has been the topic of a number of research reports. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Wall Street Zen cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Wells Fargo & Company boosted their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Barclays initiated coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target on the stock. Finally, Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $1,288.89.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.